All plans covering the drugs approved for weight loss require prior authorization
Understanding Semaglutide for Weight Loss Semaglutide (brand names Wegovy and Ozempic) is a GLP-1 receptor agonist originally developed to treat type 2 diabetes
However, a 2025 review noted only 3 RCTs, calling for larger trials (Nguyen et al., 2025)
Omeprazole Molecule Summary Molecule Description Uses Stomach ulcer Ulcer in the first part of the intestine Treating symptoms like heartburn, acid regurgitation associated to gastro-oesophageal reflux disease It is also used to prevent upper gastric bleeding A peculiar infection of the stomach called Helicobacter Pylori infection
As more people look for convenient, physician-led weight loss options, semaglutide and tirzepatide have emerged as powerful tools
Unlike a traditional syringe where you control the speed of the plunger, the Wegovy pen is a spring-loaded, single-use device